The introduction of new targeted therapy for tumours requires the introduction of new tests into a diagnostic molecular pathology laboratory. This webinar is presented by Dr Helene Schlecht, Consultant Clinical Scientist and NWGLH solid tumour scientific lead, Manchester, UK and includes what should be considered when introducting a new assay into a clinical laboratory:
• Initial considerations (need for test, cost etc)
• Choosing the starting material
• Different types of assays
• What is required for implementation
This webinar was recorded on 14th March 2024.
This video is educational and aimed at professionals working in genomics laboratories/centres as well as students. If you are affected by a genetic condition covered by this video please contact a medical professional.